ClinicalTrials.Veeva

Menu

Observational Study on the Treatment of Knee Osteochondral Lesions of Grade III-IV (LOGIC)

E

Ettore Sansavini Health Science Foundation

Status

Completed

Conditions

Degenerative Lesion of Articular Cartilage of Knee

Treatments

Procedure: knee surgery

Study type

Observational

Funder types

Other

Identifiers

NCT01554878
ESREFO08

Details and patient eligibility

About

The purpose of the study is to evaluate prospectively the outcome of treatment interventions of knee osteochondral lesions Outerbridge grade III and IV.

Full description

The main purpose of the study is to prospectively evaluate the outcome of treatment interventions with replacement, repair and regenerative approaches, of osteochondral articular lesions or defects, Outerbridge grade III and IV, in terms of symptomatic and functional recovery 12 months after surgery.

Enrollment

20 patients

Sex

All

Ages

30 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients referred to the participating centers for symptomatic treatment of degenerative lesions of the knee, which meet the following inclusion criteria:

  • symptomatic osteochondral lesions of grade III or IV (according to classification of Outerbridge;
  • Axial deviation with chondral damage, correct or not;
  • Consent to the processing of personal data, signed and dated by patient;
  • Patients of both sexes and aged between 30 and 60 years;
  • Patients willing to participate actively in the rehabilitation program and to attend post-operative follow-up visits.

Exclusion criteria

  • Patients with synovitis;
  • BMI> 30;
  • Allergy to collagen or calcium phosphate;
  • Patients with neoplastic disease;
  • Patients with metabolic disorders, thyroid diseases, immune system disorders.

Trial design

20 participants in 1 patient group

knee surgery
Treatment:
Procedure: knee surgery

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems